204
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Needle-free subcutaneous sumatriptan for triptan users requiring a change in migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and confidence

, , , , , & show all
Pages 2185-2191 | Accepted 15 Aug 2011, Published online: 26 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Stephen Silberstein. (2017) AVP-825: a novel intranasal delivery system for low-dose sumatriptan powder in the treatment of acute migraine. Expert Review of Clinical Pharmacology 10:8, pages 821-832.
Read now
Stephen D Silberstein. (2016) Considerations for management of migraine symptoms in the primary care setting. Postgraduate Medicine 128:5, pages 523-537.
Read now
Stephen D Silberstein & Dawn A Marcus. (2013) Sumatriptan: treatment across the full spectrum of migraine. Expert Opinion on Pharmacotherapy 14:12, pages 1659-1667.
Read now
S. D. Silberstein, L. C. Newman, M. J. Marmura, S. J. Nahas & S. J. Farr. (2013) Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain. Current Medical Research and Opinion 29:7, pages 861-867.
Read now
Luana Lionetto, Andrea Negro, Barbara Casolla, Maurizio Simmaco & Paolo Martelletti. (2012) Sumatriptan succinate: pharmacokinetics of different formulations in clinical practice. Expert Opinion on Pharmacotherapy 13:16, pages 2369-2380.
Read now

Articles from other publishers (4)

Sarah Vollbracht & Alan M. Rapoport. (2014) New treatments for headache. Neurological Sciences 35:S1, pages 89-97.
Crossref
John F. Rothrock, Frederick G. Freitag, Stephen J. Farr & Edward F. SmithIIIIII. (2013) A Review of Needle-Free Sumatriptan Injection for Rapid Control of Migraine. Headache: The Journal of Head and Face Pain 53, pages 21-33.
Crossref
Sarah Vollbracht & Alan M. Rapoport. (2013) The Pipeline in Headache Therapy. CNS Drugs 27:9, pages 717-729.
Crossref
James E. Frampton. (2011) Needle-Free Subcutaneous Sumatriptan. CNS Drugs 25:11, pages 983-994.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.